<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31570855</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>29</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5403</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Cell death and differentiation</Title><ISOAbbreviation>Cell Death Differ</ISOAbbreviation></Journal><ArticleTitle>LanCL1 promotes motor neuron survival and extends the lifespan of amyotrophic lateral sclerosis mice.</ArticleTitle><Pagination><StartPage>1369</StartPage><EndPage>1382</EndPage><MedlinePgn>1369-1382</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41418-019-0422-6</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive loss of motor neurons. Improving neuronal survival in ALS remains a significant challenge. Previously, we identified Lanthionine synthetase C-like protein 1 (LanCL1) as a neuronal antioxidant defense gene, the genetic deletion of which causes apoptotic neurodegeneration in the brain. Here, we report in vivo data using the transgenic SOD1<sup>G93A</sup> mouse model of ALS indicating that CNS-specific expression of LanCL1 transgene extends lifespan, delays disease onset, decelerates symptomatic progression, and improves motor performance of SOD1<sup>G93A</sup> mice. Conversely, CNS-specific deletion of LanCL1 leads to neurodegenerative phenotypes, including motor neuron loss, neuroinflammation, and oxidative damage. Analysis reveals that LanCL1 is a positive regulator of AKT activity, and LanCL1 overexpression restores the impaired AKT activity in ALS model mice. These findings indicate that LanCL1 regulates neuronal survival through an alternative mechanism, and suggest a new therapeutic target in ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Tan</LastName><ForeName>Honglin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Neuroscience &amp; Metabolism Research, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, 610041, Chengdu, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chen</LastName><ForeName>Mina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neuroscience &amp; Metabolism Research, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, 610041, Chengdu, PR China. chenmina2010@scu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pang</LastName><ForeName>Dejiang</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Neuroscience &amp; Metabolism Research, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, 610041, Chengdu, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Xiaoqiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Neuroscience &amp; Metabolism Research, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, 610041, Chengdu, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Chongyangzi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Neuroscience &amp; Metabolism Research, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, 610041, Chengdu, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Wanchun</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Neuroscience &amp; Metabolism Research, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, 610041, Chengdu, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Yiyuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Neuroscience &amp; Metabolism Research, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, 610041, Chengdu, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Neuroscience &amp; Metabolism Research, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, 610041, Chengdu, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Experimental Animal Disease Model, College of Veterinary Medicine, Sichuan Agricultural University, 611130, Chengdu, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Wanxiang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Neuroscience &amp; Metabolism Research, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, 610041, Chengdu, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bi</LastName><ForeName>Dandan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Neuroscience &amp; Metabolism Research, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, 610041, Chengdu, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Chunyu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, West China Hospital, Sichuan University, 610041, Chengdu, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shang</LastName><ForeName>Huifang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, West China Hospital, Sichuan University, 610041, Chengdu, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Worley</LastName><ForeName>Paul F</ForeName><Initials>PF</Initials><AffiliationInfo><Affiliation>The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. pworley@jhmi.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Bo</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-6161-9478</Identifier><AffiliationInfo><Affiliation>Neuroscience &amp; Metabolism Research, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, 610041, Chengdu, PR China. xiaob@sustech.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biology, Southern University of Science and Technology, 518000, Shenzhen, PR China. xiaob@sustech.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Death Differ</MedlineTA><NlmUniqueID>9437445</NlmUniqueID><ISSNLinking>1350-9047</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C485882">Lancl1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D043562">Receptors, G-Protein-Coupled</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002490" MajorTopicYN="N">Central Nervous System</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017353" MajorTopicYN="N">Gene Deletion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008136" MajorTopicYN="Y">Longevity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009928" MajorTopicYN="N">Organ Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043562" MajorTopicYN="N">Receptors, G-Protein-Coupled</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019076" MajorTopicYN="N">Transgenes</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31570855</ArticleId><ArticleId IdType="pmc">PMC7206132</ArticleId><ArticleId IdType="doi">10.1038/s41418-019-0422-6</ArticleId><ArticleId IdType="pii">10.1038/s41418-019-0422-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W, Philips T. The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci. 2013;14:248&#x2013;64. doi: 10.1038/nrn3430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;5. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G, Traynor BJ, Hardiman O, Chio A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385&#x2013;90. doi: 10.1136/jnnp.2009.183525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.183525</ArticleId><ArticleId IdType="pmc">PMC2850819</ArticleId><ArticleId IdType="pubmed">19710046</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiman-Patterson TD, Deitch JS, Blankenhorn EP, Erwin KL, Perreault MJ, Alexander BK, et al. Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS. J Neurological Sci. 2005;236:1&#x2013;7. doi: 10.1016/j.jns.2005.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2005.02.006</ArticleId><ArticleId IdType="pubmed">16024047</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. New Engl J Med. 1994;330:585&#x2013;91. doi: 10.1056/NEJM199403033300901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199403033300901</ArticleId><ArticleId IdType="pubmed">8302340</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshino H, Kimura A. Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study) Amyotroph Lateral Scler. 2006;7:241&#x2013;5. doi: 10.1080/17482960600881870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960600881870</ArticleId><ArticleId IdType="pubmed">17127563</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrante RJ, Browne SE, Shinobu LA, Bowling AC, Baik MJ, MacGarvey U, et al. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem. 1997;69:2064&#x2013;74. doi: 10.1046/j.1471-4159.1997.69052064.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1997.69052064.x</ArticleId><ArticleId IdType="pubmed">9349552</ArticleId></ArticleIdList></Reference><Reference><Citation>Beal MF, Ferrante RJ, Browne SE, Matthews RT, Kowall NW, Brown RH, et al. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann Neurol. 1997;42:644&#x2013;54. doi: 10.1002/ana.410420416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410420416</ArticleId><ArticleId IdType="pubmed">9382477</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata N, Nagai R, Uchida K, Horiuchi S, Yamada S, Hirano A, et al. Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients. Brain research. 2001;917:97&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">11602233</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogdanov M, Brown RH, Matson W, Smart R, Hayden D, O&#x2019;Donnell H, et al. Increased oxidative damage to DNA in ALS patients. Free Radic Biol Med. 2000;29:652&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11033417</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrante RJ, Shinobu LA, Schulz JB, Matthews RT, Thomas CE, Kowall NW, et al. Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation. Ann Neurol. 1997;42:326&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">9307254</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrus PK, Fleck TJ, Gurney ME, Hall ED. Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem. 1998;71:2041&#x2013;8. doi: 10.1046/j.1471-4159.1998.71052041.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1998.71052041.x</ArticleId><ArticleId IdType="pubmed">9798929</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R, Althaus JS, Ellerbrock BR, Becker DA, Gurney ME. Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis. Ann Neurol. 1998;44:763&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">9818932</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber SC, Mead RJ, Shaw PJ. Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim Biophys Acta. 2006;1762:1051&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">16713195</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H, Polymenidou M, Cleveland DW. Non&#x2013;cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol. 2009;187:761&#x2013;72. doi: 10.1083/jcb.200908164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200908164</ArticleId><ArticleId IdType="pmc">PMC2806318</ArticleId><ArticleId IdType="pubmed">19951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexianu ME, Kozovska M, Appel SH. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology. 2001;57:1282&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11591849</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M, Shaw PJ. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat Rev Neurol. 2011;7:616&#x2013;30. doi: 10.1038/nrneurol.2011.152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.152</ArticleId><ArticleId IdType="pubmed">22051914</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby J, Ning K, Ferraiuolo L, Heath PR, Ismail A, Kuo SW, et al. Phosphatase and tensin homologue/protein kinase B pathway linked to motor neuron survival in human superoxide dismutase 1-related amyotrophic lateral sclerosis. Brain. 2011;134:506&#x2013;17. doi: 10.1093/brain/awq345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awq345</ArticleId><ArticleId IdType="pmc">PMC3030763</ArticleId><ArticleId IdType="pubmed">21228060</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer H, Mayer H, Marchler-Bauer A, Salzer U, Prohaska R. Characterization of p40/GPR69A as a peripheral membrane protein related to the lantibiotic synthetase component C. Biochem Biophys Res Commun. 2000;275:69&#x2013;74. doi: 10.1006/bbrc.2000.3260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.2000.3260</ArticleId><ArticleId IdType="pubmed">10944443</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee C, Paul M, Xie L, van der Donk WA. Biosynthesis and mode of action of lantibiotics. Chem Rev. 2005;105:633&#x2013;84. doi: 10.1021/cr030105v.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cr030105v</ArticleId><ArticleId IdType="pubmed">15700960</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer H, Salzer U, Breuss J, Ziegler S, Marchler-Bauer A, Prohaska R. Isolation, molecular characterization, and tissue-specific expression of a novel putative G protein-coupled receptor. Biochim Biophys Acta. 1998;1395:301&#x2013;8. doi: 10.1016/S0167-4781(97)00178-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0167-4781(97)00178-4</ArticleId><ArticleId IdType="pubmed">9512664</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer H, Bauer H, Breuss J, Ziegler S, Prohaska R. Characterization of rat LANCL1, a novel member of the lanthionine synthetase C-like protein family, highly expressed in testis and brain. Gene. 2001;269:73&#x2013;80. doi: 10.1016/S0378-1119(01)00463-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0378-1119(01)00463-2</ArticleId><ArticleId IdType="pubmed">11376939</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Wang L, Liu Y, Xu J, Zhu G, Cang H, et al. Structure of human lanthionine synthetase C-like protein 1 and its interaction with Eps8 and glutathione. Genes Dev. 2009;23:1387&#x2013;92. doi: 10.1101/gad.1789209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1789209</ArticleId><ArticleId IdType="pmc">PMC2701572</ArticleId><ArticleId IdType="pubmed">19528316</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Chen M, Pang D, Bi D, Zou Y, Xia X, et al. Developmental and activity-dependent expression of LanCL1 confers antioxidant activity required for neuronal survival. Dev Cell. 2014;30:479&#x2013;87. doi: 10.1016/j.devcel.2014.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2014.06.011</ArticleId><ArticleId IdType="pmc">PMC4147379</ArticleId><ArticleId IdType="pubmed">25158856</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung CH, Kurien BT, Mehta P, Mhatre M, Mou S, Pye QN, et al. Identification of lanthionine synthase C-like protein-1 as a prominent glutathione binding protein expressed in the mammalian central nervous system. Biochemistry. 2007;46:3262&#x2013;9. doi: 10.1021/bi061888s.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi061888s</ArticleId><ArticleId IdType="pubmed">17305318</ArticleId></ArticleIdList></Reference><Reference><Citation>Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban PC, et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet. 1999;23:99&#x2013;103. doi: 10.1038/12703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/12703</ArticleId><ArticleId IdType="pubmed">10471508</ArticleId></ArticleIdList></Reference><Reference><Citation>Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006;312:1389&#x2013;92. doi: 10.1126/science.1123511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123511</ArticleId><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Mironets E, Osei-Owusu P, Bracchi-Ricard V, Fischer R, Owens EA, Ricard J, et al. Soluble TNFalpha signaling within the spinal cord contributes to the development of autonomic dysreflexia and ensuing vascular and immune dysfunction after spinal cord injury. J Neurosci. 2018;38:4146&#x2013;62. doi: 10.1523/JNEUROSCI.2376-17.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2376-17.2018</ArticleId><ArticleId IdType="pmc">PMC5963850</ArticleId><ArticleId IdType="pubmed">29610439</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai M, Choi SM, Yang EJ. The effects of bee venom acupuncture on the central nervous system and muscle in an animal hSOD1G93A mutant. Toxins. 2015;7:846&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4379529</ArticleId><ArticleId IdType="pubmed">25781653</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y, Zhang Y, Wen D, Duan W, An T, Shi P, et al. The modest impact of transcription factor Nrf2 on the course of disease in an ALS animal model. Lab Investig. 2013;93:825&#x2013;33. doi: 10.1038/labinvest.2013.73.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.2013.73</ArticleId><ArticleId IdType="pubmed">23711824</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaech S, Banker G. Culturing hippocampal neurons. Nat Protoc. 2006;1:2406&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">17406484</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng C, Luo T, Zhang S, Liu K, Zhang Y, Luo Y, et al. Lycopene protects human SHSY5Y neuroblastoma cells against hydrogen peroxideinduced death via inhibition of oxidative stress and mitochondriaassociated apoptotic pathways. Molecular medicine reports. 2016;13:4205&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4838073</ArticleId><ArticleId IdType="pubmed">27035331</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouali Alami N, Schurr C, Olde Heuvel F, Tang L, Li Q, Tasdogan A, et al. NF-kappaB activation in astrocytes drives a stage-specific beneficial neuroimmunological response in ALS. EMBO J. 2018;37:e98697.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6092622</ArticleId><ArticleId IdType="pubmed">29875132</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyoshi S, Tezuka T, Arimura S, Tomono T, Okada T, Yamanashi Y. DOK7 gene therapy enhances motor activity and life span in ALS model mice. EMBO Mol Med. 2017;9:880&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5494517</ArticleId><ArticleId IdType="pubmed">28490573</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JK, Shin JH, Hwang SG, Gwag BJ, McKee AC, Lee J, et al. MST1 functions as a key modulator of neurodegeneration in a mouse model of ALS. PNAS. 2013;110:12066&#x2013;71. doi: 10.1073/pnas.1300894110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1300894110</ArticleId><ArticleId IdType="pmc">PMC3718122</ArticleId><ArticleId IdType="pubmed">23818595</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph AC, Bendotti C, Blaugrund E, Hengerer B, Loffler JP, Martin J, et al. Guidelines for the preclinical in vivo evaluation of pharmacological active drugs for ALS/MND: report on the 142nd ENMC international workshop. Amyotroph Lateral Scler. 2007;8:217&#x2013;23. doi: 10.1080/17482960701292837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960701292837</ArticleId><ArticleId IdType="pubmed">17653919</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsang YM, Chiong F, Kuznetsov D, Kasarskis E, Geula C. Motor neurons are rich in non-phosphorylated neurofilaments: cross-species comparison and alterations in ALS. Brain Res. 2000;861:45&#x2013;58. doi: 10.1016/S0006-8993(00)01954-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-8993(00)01954-5</ArticleId><ArticleId IdType="pubmed">10751564</ArticleId></ArticleIdList></Reference><Reference><Citation>Nystrom T. Role of oxidative carbonylation in protein quality control and senescence. EMBO J. 2005;24:1311&#x2013;7. doi: 10.1038/sj.emboj.7600599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7600599</ArticleId><ArticleId IdType="pmc">PMC1142534</ArticleId><ArticleId IdType="pubmed">15775985</ArticleId></ArticleIdList></Reference><Reference><Citation>Esterbauer H, Zollner H, Lang J. Metabolism of the lipid peroxidation product 4-hydroxynonenal by isolated hepatocytes and by liver cytosolic fractions. Biochemical J. 1985;228:363&#x2013;73. doi: 10.1042/bj2280363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj2280363</ArticleId><ArticleId IdType="pmc">PMC1144994</ArticleId><ArticleId IdType="pubmed">3160340</ArticleId></ArticleIdList></Reference><Reference><Citation>Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, et al. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science. 1997;275:661&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">9005851</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaguchi A, Tamatani M, Matsuzaki H, Namikawa K, Kiyama H, Vitek MP, et al. Akt activation protects hippocampal neurons from apoptosis by inhibiting transcriptional activity ofp53. J Biol Chem. 2001;276:5256&#x2013;64. doi: 10.1074/jbc.M008552200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M008552200</ArticleId><ArticleId IdType="pubmed">11054421</ArticleId></ArticleIdList></Reference><Reference><Citation>Manning BD, Toker A. AKT/PKB signaling: navigating the network. Cell. 2017;169:381&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5546324</ArticleId><ArticleId IdType="pubmed">28431241</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh SH, Kwon H, Kim KS, Kim J, Kim MH, Yu HJ, et al. Epigallocatechin gallate prevents oxidative-stress-induced death of mutant Cu/Zn-superoxide dismutase (G93A) motoneuron cells by alteration of cell survival and death signals. Toxicology. 2004;202:213&#x2013;25. doi: 10.1016/j.tox.2004.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tox.2004.05.008</ArticleId><ArticleId IdType="pubmed">15337584</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin X, Ren M, Jiang H, Cui S, Wang S, Jiang H, et al. Downregulated AEG-1 together with inhibited PI3K/Akt pathway is associated with reduced viability of motor neurons in an ALS model. Mol Cell Neurosci. 2015;68:303&#x2013;13. doi: 10.1016/j.mcn.2015.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2015.08.009</ArticleId><ArticleId IdType="pubmed">26320681</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadidi M, Lentz SI, Feldman EL. Hydrogen peroxide-induced Akt phosphorylation regulates Bax activation. Biochimie. 2009;91:577&#x2013;85. doi: 10.1016/j.biochi.2009.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2009.01.010</ArticleId><ArticleId IdType="pmc">PMC2697849</ArticleId><ArticleId IdType="pubmed">19278624</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, McCullough KD, Franke TF, Holbrook NJ. Epidermal growth factor receptor-dependent Akt activation by oxidative stress enhances cell survival. J Biol Chem. 2000;275:14624&#x2013;31. doi: 10.1074/jbc.275.19.14624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.275.19.14624</ArticleId><ArticleId IdType="pubmed">10799549</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner BJ, Talbot K. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog Neurobiol. 2008;85:94&#x2013;134. doi: 10.1016/j.pneurobio.2008.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2008.01.001</ArticleId><ArticleId IdType="pubmed">18282652</ArticleId></ArticleIdList></Reference><Reference><Citation>Riboldi G, Nizzardo M, Simone C, Falcone M, Bresolin N, Comi GP, et al. ALS genetic modifiers that increase survival of SOD1 mice and are suitable for therapeutic development. Prog Neurobiol. 2011;95:133-48.</Citation><ArticleIdList><ArticleId IdType="pubmed">21816207</ArticleId></ArticleIdList></Reference><Reference><Citation>Cudkowicz ME, Pastusza KA, Sapp PC, Mathews RK, Leahy J, Pasinelli P, et al. Survival in transgenic ALS mice does not vary with CNS glutathione peroxidase activity. Neurology. 2002;59:729&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">12221165</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang SH, Li Y, Fukaya M, Lorenzini I, Cleveland DW, Ostrow LW, et al. Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat Neurosci. 2013;16:571&#x2013;9. doi: 10.1038/nn.3357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3357</ArticleId><ArticleId IdType="pmc">PMC3637847</ArticleId><ArticleId IdType="pubmed">23542689</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes AE, Ferraiuolo L, Haidet-Phillips AM, Schmelzer L, Braun L, Miranda CJ, et al. Microglia induce motor neuron death via the classical NF-kappa B pathway in amyotrophic lateral sclerosis. Neuron. 2014;81:1009&#x2013;23. doi: 10.1016/j.neuron.2014.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.013</ArticleId><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian K, Huang H, Peterson A, Hu B, Maragakis NJ, Ming GL, et al. Sporadic ALS astrocytes induce neuronal degeneration in vivo. Stem Cell Rep. 2017;8:843&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5390239</ArticleId><ArticleId IdType="pubmed">28366455</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewil M, Lambrechts D, Sciot R, Shaw PJ, Ince PG, Robberecht W, et al. Vascular endothelial growth factor counteracts the loss of phospho-Akt preceding motor neurone degeneration in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol. 2007;33:499&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pubmed">17854437</ArticleId></ArticleIdList></Reference><Reference><Citation>Peviani M, Tortarolo M, Battaglia E, Piva R, Bendotti C. Specific induction of Akt3 in spinal cord motor neurons is neuroprotective in a mouse model of familial amyotrophic lateral sclerosis. Mol Neurobiol. 2014;49:136&#x2013;48. doi: 10.1007/s12035-013-8507-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-013-8507-6</ArticleId><ArticleId IdType="pubmed">23873136</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Wang X, Vikash V, Ye Q, Wu D, Liu Y, et al. ROS and ROS-Mediated Cellular Signaling. Oxid Med Cell Longev. 2016;2016:4350965.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4779832</ArticleId><ArticleId IdType="pubmed">26998193</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng M, van der Donk WA, Chen J. Lanthionine synthetase C-like protein 2 (LanCL2) is a novel regulator of Akt. Mol Biol Cell. 2014;25:3954&#x2013;61. doi: 10.1091/mbc.e14-01-0004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e14-01-0004</ArticleId><ArticleId IdType="pmc">PMC4244203</ArticleId><ArticleId IdType="pubmed">25273559</ArticleId></ArticleIdList></Reference><Reference><Citation>Hensley K, Venkova K, Christov A. Emerging biological importance of central nervous system lanthionines. Molecules. 2010;15:5581&#x2013;94. doi: 10.3390/molecules15085581.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules15085581</ArticleId><ArticleId IdType="pmc">PMC6257760</ArticleId><ArticleId IdType="pubmed">20714314</ArticleId></ArticleIdList></Reference><Reference><Citation>Nada SE, Tulsulkar J, Raghavan A, Hensley K, Shah ZA. A derivative of the CRMP2 binding compound lanthionine ketimine provides neuroprotection in a mouse model of cerebral ischemia. Neurochem Int. 2012;61:1357&#x2013;63. doi: 10.1016/j.neuint.2012.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2012.09.013</ArticleId><ArticleId IdType="pmc">PMC3513634</ArticleId><ArticleId IdType="pubmed">23036362</ArticleId></ArticleIdList></Reference><Reference><Citation>He C, Zeng M, Dutta D, Koh TH, Chen J, van der Donk WA. LanCL proteins are not Involved in Lanthionine Synthesis in Mammals. Sci Rep. 2017;7:40980. doi: 10.1038/srep40980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep40980</ArticleId><ArticleId IdType="pmc">PMC5247676</ArticleId><ArticleId IdType="pubmed">28106097</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>